OriginalBanner 900X600

Livia Augustin, PhD

International Carbohydrate Quality Consortium (ICQC) update

Dr. Augustin is a nutrition researcher at the Clinical Nutrition and Risk Factor Modification Centre at St. Michael’s Hospital in Toronto (Canada). 

Dr. Augustin's major interest is the investigation of dietary carbohydrate quality on chronic diseases.  Dr. Augustin hypothesized that the glycemic index may be relevant in carcinogenesis; she started and led the investigations of the glycemic index in cancer risk. Dr. Augustin conceived and co-organized the International Scientific Consensus Summit on the Glycemic Index, Glycemic Load and Glycemic Response (Stresa, 2013). She has been an invited speaker at international scientific meetings and she is a Visiting Professor at the University of Catania (Italy). Dr. Augustin has many scientific publications in peer-reviewed journals and textbook chapters on carbohydrate metabolism. She is a member and coordinator of the ICQC, member of the ASN, CNS and the EFSA expert database. Dr. Augustin serves as review editor and as reviewer for international scientific journals.

International Carbohydrate Quality Consortium (ICQC) update
The International Carbohydrate Quality Consortium (ICQC) is a non-profit, worldwide organization created in 2013 in response to scientific, governmental and public needs for more clarity on the science around dietary carbohydrates quality and health. Scientific world experts joined the two-day meeting in 2013 with the goal of summarizing the evidence on the possible impact of the glycemic index, on chronic disease and release a consensus statement. Our founders envisioned the organization to move the science forward by investigating the gaps and possible solutions, creating new collaborations, encouraging scientific dialogue and harmonizing the carbohydrate discussions within and between academia, industry and governmental bodies. In order to do this we planned to meet every two years. This presentation is a summary of the main points discussed at the ICQCmeeting of June 9th 2015 in Toronto.

 

Alfred Aziz, PhD

Regulation of glycemic response/index/load claims: Health Canada’s perspective

Alfred Aziz is the Chief, Nutrition Regulations and Standards Division, Bureau of Nutritional Sciences, Food Directorate, Health Canada.

Dr. Aziz holds a bachelor and master degree in Nutrition from the American University of Beirut, Lebanon, and PhD in Nutritional Sciences from the University of Toronto. In 2005, he received the Health Canada’s Office of the Chief Scientist postdoctoral fellowship award and two years later, was appointed as a research scientist in Health Canada’s Bureau of Nutritional Sciences. His graduate, post-graduate and independent research programs included food intake regulation, as well as lipid and carbohydrate metabolism. Concurrently, Dr. Aziz became involved in several policy files, such as health claims and the development of a framework to curb childhood obesity. Between 2012 and 2015, he was a participant of the Health Canada Science Management Development Program, and occupied several leadership positions and worked on different files, including paediatric initiatives; medical marihuana regulations; risk assessment and risk management; and recently, nutrition labelling and other food and nutrition regulatory modernization initiatives.

 

Dr. Ying Bao

Tree nuts and cardiovascular mortality

Ying Bao is Associate Epidemiologist at Brigham and Women’s Hospital and Instructor in Harvard Medical School.

Dr. Bao has conducted extensive research in determining the role of insulin resistance and dysregulated energy metabolism in the pathogenesis of gastrointestinal cancer and other chronic diseases, through a comprehensive and integrative application of nutrition, biomarkers, genetics, and metabolomics. Dr. Bao has also led large studies exploring the health benefits of nuts on chronic diseases, including a landmark study demonstrating that regular nut consumption is associated with reduced overall mortality as well as mortality due to cardiovascular disease, cancer, and other chronic diseases. In the past decade, Dr. Bao has led or contributed generously to important national and international collaborative endeavors, and has contributed high quality first- and senior-authored publications in such journals as The New England Journal of Medicine, Journal of the National Cancer Institute, and American Journal of Clinical Nutrition.

 

Dr. Alan Barclay

Glycemic index labeling: The Australian Experience

Alan is an Accredited Practicing Dietitian and Nutritionist and completed a PhD at the University of Sydney in the mid 2000’s on the association between glycemic carbohydrate and the risk of developing lifestyle-related diseases. Alan is currently the Chief Scientific Officer at Glycemic Index Foundation (part-time). Alan worked for Diabetes Australia in both a full and part-time capacity, from 1998 - 2014, as Head of research.

Alan has worked in clinical dietetics and has maintained a private practice in Sydney since 1995. Alan is an official Media Spokesperson for the Dietitians Association of Australia and has appeared frequently in newspapers, magazines, radio and television news. Alan has published ~30 peer reviewed articles in the scientific literature and is a co-author of The New Glucose Revolution: Diabetes & Pre-diabetes Handbook, Low GI Diet Managing Type 2 Diabetes and The Ultimate Guide to Sugars and Sweeteners.

 

Neal Barnard, M.D.

Vegetarian diets in diabetes

Neal Barnard is an Adjunct Associate Professor of Medicine at the George Washington University School of Medicine in Washington, DC, and President of the Physicians Committee for Responsible Medicine.

Dr. Barnard has led numerous research studies investigating the effects of diet on diabetes, body weight, and chronic pain, including a groundbreaking study of dietary interventions in type 2 diabetes, funded by the National Institutes of Health. Dr. Barnard has authored more than 70 scientific publications as well as 17 books. As president of the Physicians Committee, Dr. Barnard leads programs advocating for preventive medicine, good nutrition, and higher ethical standards in research. He has hosted three PBS television programs on nutrition and health and is frequently called on by news programs to discuss issues related to nutrition and research.

Originally from Fargo, North Dakota, Dr. Barnard received his M.D. degree at the George Washington University School of Medicine and completed his residency at the same institution. He practiced at St. Vincent’s Hospital in New York before returning to Washington to found the Physicians Committee.

 

Steven N. Blair, P.E.D.

Cardiorespiratory fitness and diabetes: A review of the epidemiology

Steven N. Blair is Professor in the Departments of Exercise Science and Epidemiology and Biostatistics at the Arnold School of Public Health, University of South Carolina.

Dr. Blair is a Fellow in the American College of Epidemiology, Society for Behavioral Medicine, American College of Sports Medicine, American Heart Association, and American Kinesiology Academy; and was elected to membership in the American Epidemiological Society. Dr. Blair is a past-president of the American College of Sports Medicine (ACSM), National Coalition for Promoting Physical Activity, and the American Kinesiology Academy. Dr. Blair is the recipient of three honorary doctoral degrees--Doctor Honoris Causa degree from the Free University of Brussels, Belgium; Doctor of Health Science degree from Lander University, U.S.; and Doctor of Science Honoris Causa, University of Bristol, UK. He has received awards from many professional associations, including a MERIT Award from the National Institutes of Health, ACSM Honor Award, Population Science Award from the American Heart Association, and is one of the few individuals outside the U.S. Public Health Service to be awarded the Surgeon General's Medallion. He has delivered lectures to medical, scientific, and lay groups in 48 states and 50 countries. His research focuses on the associations between lifestyle and health, with a specific emphasis on exercise, physical fitness, body composition, and chronic disease. He has published over 550 papers and chapters in the scientific literature, and is one of the most highly cited exercise scientists with over 31,000 citations to his body of work. He was the Senior Scientific Editor for the U.S. Surgeon General's Report on Physical Activity and Health.

 

Professor Jennie Brand-Miller

GI as a marker of carbohydrate qualit

Prof. Brand-Miller has a BSc (Food Science and Technology), PhD, AM, Fellow of Nutrition Society of Australia, Fellow of Australian Institute of Food Science and Technology, Personal Chair in Human Nutrition in the School of Molecular Bioscience and Charles Perkins Centre at the University of Sydney.  

Brand-Miller is an academic and researcher with 30 years’ experience in a variety of research techniques including dietary intervention studies in pregnancy and animal models, observational cohorts, randomised controlled trials, systematic reviews and meta-analysis. Her research has focused on all aspects of carbohydrates—diet and diabetes, diet and pregnancy, insulin resistance, lactose intolerance and oligosaccharides in infant nutrition, with more than 250 scientific publications. She currently leads the Australian arm of the world’s largest diabetes prevention study (the PREVIEW study) with responsibility for its dissemination and exploitation.  She plays a major role health promotion in Australia as President of the Glycemic Index Symbol Program (www.gisymbol.com). Her popular books have translated research to practice and made the GI a household word, with over 3.5 million copies sold worldwide in 12 languages.  She Chairs the University of Sydney’s Disability Action Plan Committee, the Shepherd Centre’s Research Advisory Committee, and is a past-President of the Nutrition Society of Australia and immediate-past Chair of the National Committee for Nutrition of the Australian Academy of Science. 

 

Prof. Furio Brighenti, DrPH

In vitro digestibility of carbohydrates as a marker of carbohydrate quality

Furio Brighenti is Full Professor and Chair of Human Nutrition at the Department of Food Science and currently serves as Vice-Rector for Research of the University of Parma, Italy. He holds an MSc in Food Sciences and a DrPH in Public Health Nutrition at the University of Milan.

Prof. Brighenti was Dean of the University Degree in Gastronomic Sciences of the University of Parma (2009-2012); Vice-president of the Italian Nutrition Society (2000-2003) and, since 2009, the current President of the same society; Member of the Expert Commission “Food and School” of the Italian Ministry of Education and Research (2009-2011); Head of the Area of Human Nutrition at the Department of Public Health, University of Parma (2004- 2012) and current Head of the Human and Public Health Nutrition Area of the Department of Food Science; Advisor of the Antidiabetic Food Centre of the University of Lund (SWE) (2010-to date); Associate editor of the journal Nutrition, Metabolism and Cardiovascular Disease (2009-2012); Editor-in-Chief of the International Journal of Food Sciences & Nutrition (2012-to date); scientific Co-ordinator of the expert panel for the revision of the Italian DRVs (2010-to date); Member of the Scientific advisory board of the project Giocampus (2008-to date).

Prof. Brighenti’s research work is mainly focused on the metabolic and physiological effects of foods and food components. On these topics he published more than 130 research papers on indexed international journals (see publication details and metrics on Research ID at  http://www.researcherid.com/rid/E-4174-2010). Based on citation metrics, he has been included in the 2014 Thomson Reuters list of the Highly Cited Researchers in the field of Agricultural Sciences.

 

Prof. Dr. Fred Brouns, PhD

Fruit juice: impact on nutrient quality, obesity and diabetes

Prof Dr. Fred Brouns obtained his PhD at Maastricht University, Netherlands, entitled “Food and Fluid Related Aspects in Highly Trained athletes”, For work this he was awarded the Dutch Sports Medicine Award. Fred headed international Nutrition and Health R&D functions at Wander Dietetics, Sandoz Nutrition, Novartis Nutrition, Eridania Beghin Say, Cerestar and Cargill Inc. At the International Life Sciences Institute (ILSI) Europe he chaired the Carbohydrates Committee and in various expert panels (glycemic index, postprandial glycemia, satiety regulation). Fred became invited member of the British Nutrition Society and is a registered Biomedical Researcher as well as board member (2008-2012) of the Dutch Academy of Nutritional Sciences. Since 2008 he holds a chair in Health Food Innovation at the Faculty of Health, Medicine and Life and Sciences within the research school NUTRIM School of Nutrition and Translational Research in Metabolism of Maastricht University. Fred has over 200 publications, citations according to WoS: sum 5372, average 30.18 /item ; H-index:43.

 

Mònica Bulló, PhD

Tree nuts as part of a Mediterranean diet in diabetes

Mònica Bulló obtained a degree in Biology from the University of Barcelona (UB) and a Ph.D. by the Rovira i Virgili University with the award of Honours Thesis Ph.D.  She occupied research positions, first in the Municipal Medical Research Institute (IMIM) in Barcelona, and in the Biomedical Research Center at the Hospital Sant Joan de Reus. Until now she has occupied various teaching and research positions at the University Rovira i Virgili (URV). Since 2005, she has been a Lecturer Professor in the Department of Biochemistry and Biotechnology-URV (Human Nutrition Unit).

Her main lines of research include: 1) Mechanisms involved in pathophysiology of obesity, 2) Expression of adipokines and their relationship to metabolism, obesity and metabolic syndrome, 3) Effect of Mediterranean diet on cardiovascular risk factors, diabetes prevention and bone metabolism, 4) Effect nutrients on body weight, glucose tolerance and lipid metabolism, 5) Effect of nuts on inflammatory and oxidative parameters, 6) Effect of glycemic index and glycemic load on body weight, inflammation and endothelial function, 7) Satiety control through food structures made by novel processing; 8) Effect of pistachio intake on insulin resistance and T2D; 9) Dietary modulation of gut microbiota and its implication on health.

Throughout her scientific career as research staff she has participated in the design and conduction of various research projects, being principal investigator on several national and international projects. In 2005 she obtained a scholarship in the program "State of Research outside Catalonia (2004BE 00018) "of the Generalitat de Catalunya which allowed her a stay of 7 months and starting a line of collaborative research in the Neuroendocrine & Obesity Biology Unit (Professor P. Trayhurn - University of Liverpool, UK).

Mònica Bulló has published more than 110 original papers in national and international journals with a cumulative impact factor, according to the SCI, greater than 480, with more than 95 publications in the top quartile of their specific area.

 

Jared Carlberg, Ph.D.

Jared Carlberg, Ph.D., is Associate Professor of Agribusiness & Agricultural Economics and Associate Dean (Academic) in the Faculty of Agricultural and Food Sciences at the University of Manitoba.

Dr. Carlberg's research focuses on the economic costs of food-related chronic diseases, consumer preferences for food products, and the relationships between food intake decisions and self-perceptions of the impacts of food choice on future health states.

 

Tim Church, M.D., M.P.H., Ph.D.

Optimal exercise prescription for type 2 diabetes mellitus

Tim Church is one of the USA’s leading physicians in exercise and obesity research.  As Chief Medical Officer of ACAP Health Consulting, Dr. Church seeks to reduce the production of and destruction from disease by guiding the company in the creation of clinical strategies and disease specific battle plans.  He brings to ACAP Health, dynamic expertise in preventative health, nutrition and the power of physical activity.

After receiving a Bachelor of Science in Animal Physiology from UC-Davis, Church received his Medical Doctorate and Ph.D. from Tulane University School of Medicine in new Orleans, LA.  During his preventive medicine residency training, he also obtained a master’s degree in Public Health.

Dr. Church is a professor and director of the Preventive Medicine Research Laboratory at Pennington Biomedical Research Center at Louisiana State University where he promotes healthy living through research and education in nutrition and exercise biology.  As the former vice president of medical and laboratory research at The Cooper Institute in Dallas, he established himself as an international leader in some of the most comprehensive studies on human performance and disease prevention. Church has received numerous awards for his research in preventative health and is frequently used as an expert source for preventative health stories with major national media outlets.  As a consultant to the U.S. Department of Health and Human Services’ Physical Activity Guidelines Advisory Committee, Church contributed to their national report published in 2008.  He has also authored more than 150 research articles and co-authored Move Yourself, The Cooper Clinic Medical Director’s Guide to All Healing Benefits of Exercise (Even at Little!).

 

Michael E. Farkouh, MD, FRCPC, MSc, FACC, FAHA


Peter Munk Chair in Multinational Clinical Trials, University Health Network; Director of the Heart and Stroke/ Richard Lewar Centre of Excellence in Cardiovascular Research; Professor of Medicine, University of Toronto

Dr. Farkouh is the Director of the Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Investigation and the Peter Munk Chair in Multinational Clinical Trials at the Peter Munk Cardiac Centre, both at the University of Toronto, as well as Professor of Medicine at the University of Toronto. He is a graduate of the Schulich School of Medicine at Western University. Dr. Farkouh completed his internal medicine and cardiology training at the Mayo Clinic and the Icahn School of Medicine at Mount Sinai New York respectively and holds an MSc in Clinical Epidemiology from McMaster University. Prior to his current appointments, he served as the founding director of the Mount Sinai Cardiovascular Clinical Trials Unit in New York City. He has published over 140 papers largely on acute coronary syndromes and cardiovascular prevention. He has mentored numerous international residents and fellows and is active in teaching clinical research methodology. Dr. Farkouh is internationally known for his work on the management of acute coronary syndromes in the emergency room. He has a special interest and expertise in the field of cardiovascular disease in diabetic patients. He is currently the project officer for numerous clinical trials on questions related to diabetes and heart disease including the NIH-sponsored FREEDOM trial and coordinates clinical studies in Grenada and Colombia. He chairs the committee on diabetes and heart disease at the Banting and Best Centre and at the University of Toronto. Dr. Farkouh has received the gold medal from John Paul II Hospital in Krakow and was the Teacher of the Year at the Mayo Clinic.

 

Hertzel C. Gerstein, MD, MSc, FRCPC

Why do we Need Large, Pragmatic Randomized Outcomes Trials of Nutritional Interventions?

Dr. Hertzel C. Gerstein is an Endocrinologist and Professor at McMaster University and Hamilton Health Sciences, where he holds the Population Health Institute Chair in Diabetes Research. He is also Director of the Division of Endocrinology & Metabolism, Director of the Diabetes Care and Research Program and Deputy Director of the Population Health Research Institute. He has received several honors including the Canadian Diabetes Association’s Young Scientist Award (1999), Frederick G. Banting award (1999), Charles H. Best award (2007) and Lifetime Achievement Award (2012).

Dr. Gerstein has led the application of large simple outcome trials to people with diabetes globally, and developed the concept of dysglycemia as an important risk factor for many of the serious health outcomes that afflict people with an elevated glucose level regardless of diabetes status. His research spans over 50 countries, and has been funded by the Canadian Institutes of Health Research, the National Institutes of Health, the Heart and Stroke Foundation, the Canadian Diabetes Association and Industry.

Dr. Gerstein has published more than 300 papers, editorials and commentaries, mainly on diabetes-related issues.

 

Osama Hamdy, M.D., Ph.D.

Meal replacements in diabetes

Dr. Hamdy is the Medical Director of the Obesity Clinical Program, Director of Inpatinet Diabetes Management, clinical investigator and senior endocrinologist at Joslin Diabetes Center in Boston and Assistant Professor of Medicine at Harvard Medical School. Dr. Hamdy completed his fellowship in Endocrinology, Diabetes and Metabolism at University of Missouri and Harvard University.  

Dr. Hamdy and colleagues’ research led to the first discovery that obese adults who lost 7% of their initial weight had significant improvement in their vascular endothelial function. This improvement may eventually prevent progression of atherosclerosis and coronary artery disease. Dr. Hamdy was a co-investigator of several landmark studies; including the NIH-funded “Diabetes Prevention Program” and “the Look AHEAD Study”. Dr. Hamdy founded the “Weight Achievement and Intensive Treatment-Why WAIT?” program at the Joslin Diabetes Center in 2005, which is currently implemented Nationally and Internationally. He is the author of the Haravard Health Publication The Diabetes Breakthrough, which outlines his experience with long-term diabetes weight management.  

Dr. Hamdy chaired the task force that developed the Joslin Nutrition Guidelines. He is also member of the Nutrition Committee of the American Association of Clinical Endocrinologist (AACE) that developed many of the current guidelines for nutrition and obesity management. Dr. Hamdy co-chairs the global task force that developed the Transcultural Diabetes Nutrition Alogrithm (tDNA) and is currently leading the effort to improve the quality of diabates care across the globe through implementing an effective transcultural lifestyle intervention.

Dr. Hamdy was nominated by the Harvard Medical School for best mentor award of 2013 and was given the Compassionate Caregiver Award of the Kenneth Scwartz Center and the prestigous Michaela Modan awrd of the American Diabetes Association. Dr. Hamdy has more than 150 peer-reviewed original articles, reviews, chapters, conference abstracts and proceedings. He is on the editorial board of several medical journals including US Eendocrinology, Journal of Nutritional Disorders & Therapy and 2-times section editor of The Current Diabetes Report. He is a member of the editorial review board of many scentific medical journals including JAMA, Diabetes Care, Lancet, Obesity Research and the Expert Opinions.

 

Anthony Hanley, PhD

Dietary patterns rich in dairy in diabetes prevention

Dr. Hanley received his PhD in epidemiology from the University of Toronto in 2000, and was subsequently a post-doctoral fellow in the Division of Clinical Epidemiology, University of Texas Health Sciences Centre at San Antonio. From 2002-2005 he was a research scientist in the Leadership Sinai Centre for Diabetes at Mount Sinai Hospital. Since 2005 he has been a faculty member of the Department of Nutritional Sciences, University of Toronto, where he is currently an associate professor and holds a Tier II Canada Research Chair in Diabetes Epidemiology.

Dr. Hanley’s research interests include the metabolic and nutritional epidemiology of obesity, insulin resistance and type 2 diabetes, with a particular focus on diabetes in Aboriginal Canadian communities and other high-risk populations.

 

Edward S. Horton, MD

Lessons learned from the LookAhead Trial

Edward Horton is Professor of Medicine, Harvard Medical School and Senior Investigator at the Joslin Diabetes Center. He received his medical degree from Harvard Medical School in 1957. Following internship in surgery at Johns Hopkins Hospital and military service in Germany, he received residency/fellowship training in pathology at Dartmouth Medical School and in medicine and endocrinology at Duke University Medical Center. In 1967, he went to the University of Vermont College of Medicine, where he worked for 26 years as Director of Endocrinology and Metabolism and then as Chairman of the Department of Medicine. In 1993, he was appointed Professor of Medicine at Harvard Medical School and Medical Director of the Joslin Diabetes Center.

Currently Dr. Horton is a Senior Investigator at the Joslin Diabetes Center. He has over 450 publications and is the recipient of several awards, including the ADA Banting Medal for Distinguished Service, the ASCN Robert H. Herman Award, the Mizuno Award and Lectureship, the IDF John A. Galloway Award, the ADA Outstanding Physician Educator Award, the Endocrine Society Distinguished Physician Award, the ADA Albert Renold Award and the JK Lilly Award. He is past president of the American Diabetes Association and the American Society for Clinical Nutrition and served as Chairman of the National Diabetes Advisory Board.


David J A Jenkins, MD, D.Sc, Ph.D

The “Lifestyle Portfolio Trial” rationale and design

Educated at Oxford University, Dr. Jenkins is currently a professor in both the Departments of Nutritional Sciences and Medicine, Faculty of Medicine, University of Toronto, a staff physician in the Division of Endocrinology and Metabolism, the Director of the Clinical Nutrition and Risk Factor Modification Center, and a Scientist in the Li Ka Shing Knowledge Institute of St. Michael's Hospital.

Dr. Jenkins has served on committees in Canada and the United States that have formulated nutritional guidelines for the treatment of diabetes and recommendations for fibre and macronutrient intake (fat protein and carbohydrates) for the general population (the recommended daily intakes e.g. that you see on food labels) under the joint United States-Canada DRI system (RDAs) of the National Academy of Sciences (Washington, DC).  He and his colleagues developed the cholesterol lowering  dietary portfolio, that  was the only dietary approach referenced in 2004 Guidelines update of the US National Cholesterol Education Program (ATP III) for Americans and is one of three diets recommended by the Canadian Cardiovascular Society (CCS) guidelines for Canadians for 2012. He has received many National and International awards in recognition of his contribution to nutrition research. He believes in the value of plant based diets, and that a major effort is required to mount large studies to determine the extent of their health benefits. He also believes that diets have to be environmentally sustainable.

 

Peter J. Jones, Ph.D.


Peter J. Jones is a Canada Research Chair in Functional Foods and Nutrition, and Director of the Richardson Centre for Functional Foods and Nutraceuticals at the University of Manitoba where his main appointment is in the Department of Food Science with a cross-appointment in Human Nutritional Sciences. 

Dr. Jones’ research interests cover cholesterol, fat and energy metabolism.  He has applied novel stable isotope methodologies to examine the response of these areas of metabolism to dietary intervention.  His research group has been active in exploring the dietary determinants which control cholesterol biosynthesis absorption and turnover in humans, as well as how plant sterols act in functional foods as cholesterol-lowering agents.  Dr. Jones has published over 321 peer-reviewed research articles and reviews in international journals, as well as chapters in leading nutrition textbooks.

 

Michael Keenan, PhD

Review of mechanisms – Findings from Animal Models

Michael Keenan earned his PhD from the University of Illinois-Urbana in Nutritional Sciences in 1984.  He remained at University of Illinois for two years as a post-doc before moving to Louisiana State University in 1986. 

After ten years of investigation of the interaction between vitamin D and the ultratrace mineral boron, Michael Keenan changed to obesity research.  In 2001 Michael Keenan teamed up with Roy Martin who had recently moved to LSU from Georgia and began doing mechanistic, proof-of-concept rodent studies with resistant starch.  This partnership has been very fruitful as far as publications and grant funding.  Initially their research focused on the mechanism of body fat reduction in rodents with diets with resistant starch using isocaloric control diets.  In recent years their focus has moved into the effects of resistant starch on the microbiota.

 

Carl (Chip) Lavie, Jr., M.D., FACC, FACP, FCCP

Fitness is more important than fatness in diabetes


Dr. Lavie graduated from Louisiana State University Medical School in 1983 and completed internal medicine residency at Ochsner and fellowship in cardiovascular diseases at Mayo, where he joined the faculty in 1989. Dr. Lavie is Professor of Medicine and Medical Director, Cardiac Rehabilitation and Preventive Cardiology; Director, Exercise Testing Laboratory; and Staff Cardiologist, Echocardiographic Laboratory at the John Ochsner Heart and Vascular Institute in New Orleans, Ochsner Clinical School-The University of Queensland School of Medicine and he previously served for 10 years as Associate Director of the Internal Medicine Training program. He served as a Consultant in the Department of Preventive Medicine at the Pennington Biomedical Research Center in Baton Rouge, Louisiana from January 2012-October 2014.

Dr. Lavie’s research interests include cardiac rehabilitation and prevention, lipids, hypertension, obesity, and exercise, as well as noninvasive testing, encompassing echocardiography, exercise testing, and nuclear cardiology.  He is the author of over 800 medical publications including two cardiology textbooks, and 40 book chapters.  Dr. Lavie serves as a frequent lecturer, reviewer for several medical journals, and is Associate Editor and Cardiovascular Section Editor of the Mayo Clinic Proceedings and is Editor in Chief of Progress in Cardiovascular Diseases and serves on the Editorial Boards of the Journal of the American College of Cardiology, American Journal of Cardiology, Journal of Cardiopulmonary Rehabilitation Prevention,  and over 20 other Journals.  From 2011 till now, he has served as Chairman of the Document Oversights Committee for AACVPR.  For the years 2003 and 2004 he served as Chairman of Vascular, Hypertension and Prevention for the American College of Cardiology and he has been an elite reviewer for JACC for 7 of the last 8 years, also receiving the Simon Dack Award as a life-time, hall of fame, reviewer. In 2013, he gave Key-Note lectures for both the American College of Sports Medicine and the Cardiac Rehabilitation one for the AACVPR, where he received the 2013 Research Award.

From a personal stand-point, Dr. Lavie is an avid sports fan and competitive runner, with personal records in the 5K, 10K, Half-Marathon and Marathon of 18:30,38:30,1:24:30, and 3:10, respectively. He is the author of The Obesity Paradox, released in April 2014.

 

Thomas Linn, MD

Slowly and rapidly absorbed carbohydrates on postprandial metabolism in type 2 diabetes


Thomas Linn received his MD degree studying nutritional changes in the lipid composition of red blood cells. He worked as a junior researcher at Rudolf-Buchheim-Institute for Pharmacology, Giessen. Then he started clinical training in internal medicine, endocrinology and metabolism completing with board examination. He chose the field of experimental diabetology for his main thesis working on the biology of pancreatic islets and the role of inflammatory processes in the damage of insulin producing cells. Since 1999 he has been Head of Clinical Research Unit at Medical Clinic 3 of University Hospital, Giessen. In 2006 he accepted a call from Justus- Liebig University to become Professor of Internal Medicine with focus on the pathophysiology of metabolism and nutritional medicine. His research is supported by different public and private sponsors; he is founding member of the Committee of Giessen Graduate School for the Life Sciences.

 

Dr. Simn Liu

Nutritional strategies to modifying glycemic response for diabetes and cardiovascular risk prevention

Currently, Dr. Liu is Professor of Epidemiology at Brown School of Public Health and Professor of Medicine at the Alpert School of Medicine, director for both the laboratory of Molecular Epidemiology and Nutrition and Brown Center for Global Cardiometabolic Health. Dr. Liu has served on committees/study sections for the NIH, the CDC, the WHO and FAO of the United Nations addressing policy issues related to public health and nutrition.

Dr. Liu’s work unites molecular genetics, nutrition, physiology and clinical medicine. His research focus include: 1) investigation of genetic, nutritional, and environmental influences and their interactions as potential determinants for health and chronic diseases; 2) critical and systematic assessment of relative mediating effects of these potential determinants for cardiometabolic disorders and their distributions in diverse populations; 3) application of knowledge to improve understanding of health and diseases for individuals and populations.

 

Geoffrey Livesey, BSc, PhD

Achieving low glycaemic response diets within food-based approaches to healthy eating   

Geoff is a nutritional biochemist now in consultancy worldwide as director of Independent Nutrition Logic Ltd  (UK). Formerly he was at the Universities of Surrey (B.Sc 1st. Biochem), Keele (Ph.D. Cell biol.), Oxford (Post-doc clin metab) and East Anglia (lecturer) in the UK. His first post was with Marie Curie MF Cancer Res (Surrey, UK). His research interests has seen associated with several university hospitals, Radcliff (Oxford), Addenbrooks (Cambridge) and Norfolk and Norwich (Norfolk), and he was Principal scientist at the Institute of Food Research (Norwich, UK).

Dr. Livesey’s interest in metabolic research began while at the MRC Metabolic Research Laboratory (Oxford) led by Sir H. A. Krebs.  Geoff had grants and commissions from various organisations (EC, FAO, MRC, AFRC/BBSRC, MAFF, ILSI, EPA, CCC) and contributed to the work of several expert groups (BNF,LSRO, ILSI, FAO, WHO, HC). Current memberships include AfN, ASN, NS, Diabetes UK, RSM, ICQC, SENSE, and Acumentia.

 

Prof. Livio Luzi, M.D.

High-carbohydrate vs. low-carbohydrate diets in diabetes: effect on metabolic control


Livio Luzi, M.D., is Professor of Endocrinology at the University of Milan and is the Director of the Center for Research on Metabolism ate the IRCCS Policlinico San Donato in Milan. Prof. Luzi was also Adjunct Professor of Surgery at the University of Miami and a Visiting Scientist at the Diabetes Research Institute.

After receiving his medical degrees from the University of Milan, Prof. Luzi completed research fellowships in Endocrinology at Yale University and in Diabetes/Metabolism at the University of Texas Health Science Center.  From 1993-1996 he was on the faculty of Brigham and Women's Hospital, Harvard Medical School as an Assistant Professor, before returning to Italy.

Prof. Luzi’s work focuses on the study of the physiology and pathophysiology of metabolism in different clinical conditions such as acute and chronic diseases related to the cardiovascular such as, diabetes, obesity, high blood pressure, gout, abnormal homocysteine cycle, insulin resistance, metabolic syndrome, dyslipidemia, rare diseases/genetic metabolism with phenotypic manifestations at cardiovascular level.

 

Dr. Berna Magnuson

Safety and metabolic effects of low-calorie sweeteners


Berna Magnuson, Ph.D, ATS is an internationally recognized food toxicologist and a Fellow of the Academy of Toxicological Sciences. She holds degrees in food and nutritional sciences and worked in the food industry in quality assurance and product development before undertaking graduate training in food toxicology at Universities of Saskatchewan and Manitoba. Berna worked as a professor for 15 years, at the University of Idaho and University of Maryland, conducting research and teaching food, nutrition and toxicology courses, before returning to Canada. She is currently managing her own consultancy practice and teaches food regulatory courses at the University of Toronto. As a consultant, she provides expertise in food regulations, nutrition and toxicology to food, beverage, and dietary supplement manufacturers and ingredient industries, as well as health professional and consumer associations.

Dr. Magnuson has extensive experience and expertise in low calorie sweetener safety, and serves as an expert advisor and speaker on this topic around the world. She has published numerous peer-reviewed articles, book chapters, and professional articles, is on the editorial board of two journals, and is an active member of various professional associations.

 

Jim Mann, CNZM, PhD, DM, FRACP, FFPHM, FRSNZ

Dietary fibre as a marker of carbohydrate quality

Professor in Human Nutrition and Medicine, University of Otago, Dunedin, New Zealand

Jim Mann has been Professor in Human Nutrition and Medicine at the University of Otago and Consultant Physician (Endocrinology) in Dunedin Hospital for the past 28 years. Previously he was a University lecturer at Oxford and a Physician in the Radcliffe Infirmary and John Radcliffe Hospital. He is Director of the World Health Organisation (WHO) Collaborating Centre for Human Nutrition, the Edgar Diabetes and Obesity Research Centre at the University of Otago and principal investigator for the Riddet Institute, a national Centre of Research Excellence at Massey University.  His research has been in the fields of lipids and carbohydrates as they relate to diabetes, coronary heart disease and obesity. He has been involved with national and international government and nongovernmental organisations in guideline development relating to diabetes, cardiovascular disease, cancer and nutrition.

 

John C. Peters, PhD

Low calorie/no calorie sweetener in diabetes


John Peters is Professor of Endocrinology and Metabolism at the University of Colorado, School of Medicine and Chief Strategy Officer of the Anschutz Health and Wellness Center. 

Dr. Peters is a leading researcher and strategist in nutrition, obesity, diabetes and related diseases.  Prior to joining the Colorado faculty in 2011 he spent 26 years in research and development at the Procter & Gamble Company, where he conducted research, technology and product development programs in areas including nutrition, obesity, diabetes, and metabolism.  Dr. Peters has published over 130 scientific articles and book chapters and is co-author of the Step Diet Book.  He is co-founder and CEO of the America on the Move Foundation and is past President of the ILSI Center for Health Promotion.  He has served on two Institute of Medicine committees on the prevention of childhood obesity.

 

Andreas F. H. Pfeiffer, MD

DNSG Dietary guidelines update

Dr. Pfeiffer is Full Professor of Internal Medicine and Director of the Department of Endocrinology, Diabetes, and Nutrition at the Charité University Hospital, Berlin, Germany, and Head of the Department of Clinical Nutrition at the German Institute of Human Nutrition in Potsdam.

This followed a position as senior consultant and lecturer and Associate Professor of Internal Medicine at the Bergmannsheil University Hospital, Ruhr University, Bochum until 2000. Dr. Pfeiffer’s current honorary positions include Chairman of the Nutrition Board of the German Diabetes Association (DDG). He was President of the German Endocrine Society (DGE) from 2008 until 2011 and Chairman of the Diabetes and Nutrition Study Group (DNSG) of the EASD from 2007 until 2012. In 2012, Dr. Pfeiffer was Chairman of the Local Organising Committee of the 48th EASD Annual Meeting in Berlin. Dr. Pfeiffer was Co-Editor of Diabetologia from 2003 – 2006, and currently serves on several editorial boards. He has published well over 300 articles. In 1990 he was presented with the prestigious German Association of Internal Medicine’s Theodor Frerichs Award. Further awards include a Herman and Lilly Schilling Professorship, 1992-1997, the Hippocrates Prize of the Greek Association of Internal Medicine in 2013 and, most recently, the German Society of Endocrinology’s Berthold Medal. His research interests include the pathogenesis of diabetes mellitus type 2, interaction of metabolic and hormonal regulatory circuits with nutrition, genetic background and phenotype in causing disease risks for type 2 diabetes and atherosclerosis, treatment strategies for type 2 diabetes, and neuroendocrinology of energy balance.

 

 

Dr. Dan Ramdath, PhD

Dr. Dan Ramdath is a Research Scientist in Human Nutrition at the Guelph Food Research Centre, Agriculture and Agri-Food Canada, where his research focuses on validating the health promoting properties of food to support the regulatory framework for health claims substantiation.

Previously, Dr. Ramdath was Chairman, Department of Preclinical Sciences, University of the West Indies, Trinidad, and remains involved in several initiatives that promote the use of credible evidence for health policy formulation.  His early work on micronutrient metabolism has contributed significantly to current WHO clinical guidelines for management of malnourished children.

Dr. Ramdath has served on several WHO/PAHO Technical Committees on promoting healthy eating and prevention of childhood obesity.

 

Raylene A Reimer, PhD, RD

Metabolic benefits of prebiotic fibre intake


Dr. Reimer is Professor, Faculty of Kinesiology and Department of Biochemistry & Molecular Biology, Cumming School of Medicine (University of Calgary).  She is a Professor in the Faculty of Kinesiology and Cumming School of Medicine at the University of Calgary. She is also a Registered Dietitian.  She completed her PhD in Nutrition & Metabolism at the University of Alberta and a two year postdoctoral fellowship at the Nestle Research Centre in Switzerland.

Dr. Reimer's research focuses on the role of diet in regulating energy intake and gut microbiota in the context of obesity and type 2 diabetes. Dr. Reimer has developed animal models to study how diet during pregnancy and early postnatal life influences obesity risk. Her studies have identified unique dietary fibre sources as potentially valuable nutritional components in managing body weight. Translating findings from animal models to human clinical studies is a key way in which Dr. Reimer spans bench to bedside discovery and application. Her ongoing clinical trials help take evidence-based findings into application. She was honored in 2012 with the Centrum New Scientist Award for Outstanding Research by the Canadian Nutrition Society.

 

Prof. Gabriele Riccardi, PhD

Whole grains as a marker of carbohydrate quality


Gabriele Riccardi is Full Professor of Endocrinology and Metabolic Diseases at the “Federico II” University in Naples, Italy, where he is Director of the Master Course in Human Nutrition and Head of the Diabetes, Nutrition and Metabolism Unit of the University Hospital. He was President of the Società Italiana di Diabetologia (SID) from 2010 to 2012. Prof. Riccardi is member of the Joint Committee of the European Society of Cardiology and the European Atherosclerosis Society for the Guidelines on Management of Dyslipidaemias and is International Fellow of the American Heart Association. He is on the scientific committee of the Barilla Center for food and nutrition and of the Nutrition Foundation of Italy; he is member of the International advisory Board of the Antidiabetic Food Center, Lund University, Sweden.

Author of over 300 in extenso publications in international scientific journals listed in Pub Med (total impact factor > 600), Gabriele Riccardi has held invited lectures at major national and international conferences and in many universities all over the world.

 

Dr. Ulf Risérus, PhD

The Nordic diet in diabetes

After postdoctoral training at Oxford Centre of Diabetes, Endocrinology and Metabolism, Oxford University, Risérus´ was in 2009 appointed associate professor in clinical nutrition and metabolism at the Medical Faculty, Uppsala University, Sweden. He is leading a research group targeting dietary prevention of obesity and its related diseases. Specific expertise concerns the role of dietary fats and Nordic dietary patterns in cardiometabolic diseases. Risérus is since 2012 the president of the Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes (EASD), a pan European study group that develops evidence-based nutritional guidelines for the treatment of type 2 diabetes.

 

Denise Robertson, PhD

Clinical evidence – Findings from human trials

Denise Robertson has a PhD in Clinical Nutrition from the University of Newcastle and is a registered Nutritionist.

Dr. Robertson's interest has always been in the complex interplay between the gastrointestinal tract and whole-body physiology; nutrition is implicated now as both the “cause” and “treatment” for many conditions such as obesity and type 2 diabetes. After working in Oxford for 7 years she now forms part of the Metabolic Research Team at Surrey University, working entirely in human models of human disease. In addition to nutritional research, she has active links with chronobiology researchers looking at the effects of sleep and clock genes on diabetes risk in addition to the role of gut microbiota in diabetes. She has won awards for her translational work: The Nutrition Society David Cuthbertson Medal (2006), the Association for the Study of Obesity Young Achiever Award (2008) and the University of Surrey researcher of the year (2011).

 

Joan Sabaté, MD, DrPH

Tree nuts in the management of obesity, diabetes, and cardiometabolic risk


Joan Sabaté is Professor of Nutrition and Epidemiology at Loma Linda University’s School of Public Health.  From Spain, Dr. Sabaté is a board certified physician in internal medicine.  In 1989 he obtained the degree of Doctor of Public Health in Nutrition from Loma Linda University and became a faculty in the Department of Nutrition.  From 1997 to 2013 he served as Chair of the Department.

Dr. Sabaté was principal investigator in the study that directly linked the consumption of walnuts to significant reductions in blood serum cholesterol.  His landmark findings were published in the New England Journal of Medicine and received the attention of nearly 400 media sources, both national and international.  Bringing the research full circle Archives of Internal Medicine has recently published the findings of his pooled analysis of 25 intervention trials establishing the benefits of nut consumption on blood lipid levels and lowering the risk of heart disease. He is currently the co-principal investigator on the Walnuts and Healthy Aging Study (the WAHA Study), a dual-center clinical trial with Hospital Clinco in Barcelona that includes 700 subjects.

Dr. Sabaté is frequently asked to speak at scientific symposia as well as health and nutrition conferences throughout the United States, Europe and Asia.  He has been published in many scientific journals both as principal and co-author and is the editor of the book Vegetarian Nutrition published in 2001.  He also served as chairman for the Sixth International Congress on Vegetarian Nutrition held on the campus of Loma Linda University in February 2013.

 

Jordi Salas-Salvado, Md, PhD

The Mediterranean diet in diabetes
A Mediterranean intensive lifestyle intervention: Predimed Plus


Institution: Human Nutrition Unit, Department of Biochemistry & Biotechnology, Sant Joan University Hospital, Faculty of Medicine of Reus, Rovira i Virgili University, Spain; Pere Virgili Institute of Health Research; CIBER Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Spain.

Dr Salas-Salvado is Professor of Human Nutrition and Bromatology at the Faculty of Medicine and Health Sciences (Rovira i Virgili University).  He is Head of Nutrition of the Internal Medicine Service, Sant Joan University Hospital of Reus and Vice-Dean / Head of Studies of the Degree in Human Nutrition and Dietetics of the Rovira i Virgili University.  He is also Distinguished Professor at the Universitat Rovira i Virgili.

In recent years, the expertise and research lines of Dr Salas are focused on human clinical trials evaluating the effect of diets and dietary compounds on obesity, type 2 diabetes mellitus, metabolic syndrome and cardiovascular disease. Since 2005, he has been one of the leaders of PREDIMED STUDY, considered the best clinical trial evaluating the effect of the Mediterranean Diet on cardiovascular diseases. He is the coordinator and a member of the Steering Committee of the PREDIMED-PLUS STUDY, a multi-centre, randomised, primary prevention trial on 6000 overweight or obese participants (55-75 years) with metabolic syndrome. The project aim is to determine the effect on adiposity, cardiovascular disease and mortality and quality of life, of an intensive weight loss intervention based on a traditional hypocaloric Mediterranean Diet, physical activity promotion and behavioural therapy compared to a less intensive program using Mediterranean diet (without energy restriction or physical activity). The recruitment started in September 2013 and will finish in June 2016. Final results will be available in 2020.

Since 1983 Dr. Salas has directed 18 research projects financed by public bodies and 23 projects in conjunction with the pharmaceutical or food industries. He has published more than 290 original articles in national and international journals, as well as numerous reviews and editorials. Editor of 6 books, he has also co-authored more than 50 books.

 

Dr. W.H.M. Saris

Glycemic response/index/load for weight management

Wim H.M. Saris MD, PhD, Professor of Human Nutrition at the Faculty of Health, Medicine and Life Science of the Maastricht University, The Netherlands. In 1992 he initiated the Nutrition and Toxicology Research Institute NUTRIM and was the scientific director till 2005. From 2005 till 2014 he was part-time Corporate Scientist Human Nutrition at DSM, Nutritional Ingredients division.

He is author or co-author of 7 books and over 450 scientifically refereed articles dealing with topics like nutrition, obesity, type 2 diabetes, exercise physiology, cancer cachexia, functional foods and nutrigenomics. He coordinated a number of EU funded projects among others CARMEN and DIOGENES and served many national and international committees among others the Dutch Health and Nutrition Council and the Scientific Committee on Food (SCF now EFSA) of the European Commission in Brussels and the European Technology Platform (ETP) initiative Food for Life and chairmen of the EU Joint Programming Initiative (JPI)  Healthy diet for a healthy life.

 
Ursula Schwab, PhD

Dietary patterns rich in healthy oils in diabetes


Ursula Schwab, PhD, is an associate professor (nutrition therapy) at the University of Eastern Finland (UEF). She works also as a clinical nutritionist at the Kuopio University Hospital. Her expertise is in planning and conducting randomized controlled dietary interventions regarding e.g. the effects of dietary fat, fish, berries and whole grain products, and the healthy Nordic dietary pattern on lipid and glucose metabolism including nutrigenomics, lipidomics and metabolomics approaches. Her research group is partly funded by the Spearhead funding of UEF. She has been involved in the updating of the Nordic and Finnish Nutrition Recommendations, and several national good practice guidelines.

 


Professor Luc Tappy

Fructose in diabetes: friend or foe?


Luc Tappy was born in Lausanne in 1957. He graduated from medical school and obtained his MD degree at Lausanne University in 1981. He was then trained in the Department of internal medicine, Centre Hospitalier Universitaire Vaudois, and in the Diabetes section, Temple University Hospital, Philadelphia, PA.

Since 1988, he has been a senior researcher at the Institute of Physiology, Lausanne University School of Medicine. His studies focused on nutrition, physical exercise and metabolism in healthy individuals and in various clinical conditions, such as diabetes, obesity, organ transplant patients and critically ill patients. In 2002, he was appointed full professor of physiology at the Department of Physiology of the University of Lausanne, and associate physician at the Division of Endocrinology and Metabolism of the CHUV. He has also been invited professor at the Centre Hospitalier Sart Tilman in Liège, Belgium (1998-2001), and in the Department of Nutrition at the University of California at Berkeley (1995).

His present research is essentially focused on the environmental factors involved in the present epidemics of obesity and type2 diabetes. Several studies are thus conducted to evaluate the role of dietary sugars (more specifically fructose in carbonated beverages) in the development of obesity and insulin resistance. Several other studies are aimed at assessing and evaluating the role of sport and physical activity in the prevention of metabolic disorders.

 

Silvia Valtueña Martínez, MD, PhD

Regulation of glycemic response/index/load: EFSA’s perspective


Silvia Valtueña Martínez is Senior Scientific Officer at the (human) Nutrition Unit of the European Food Safety Authority (EFSA). The Nutrition Unit deals with the scientific evaluation of health claims made on foods, novel foods, infant formulae/dietetic foods, dietary reference values and upper tolerable intake levels of nutrients, and food allergens for labelling purposes. After 2.5 years of post-doctoral training at the Harvard Medical School (Boston, MA, USA) and two years of post-doc Marie Curie fellowship at the National Institute of Nutrition in Rome (Italy), she underwent a 5-year training in Internal Medicine at the University of Parma (Italy). She conducted independent research in several branches of human nutrition, including the relationship between diet and the development of chronic diseases, namely obesity, osteoporosis, diabetes and cardiovascular diseases.

 

Thomas MS Wolever, PhD

Glycemic response/index/load: Methodological issues


Thomas Wolever obtained a Bachelor of Medicine and Bachelor of Surgery from Oxford University, UK in 1980, a PhD in Nutritional Sciences from the University of Toronto in 1986 and a Doctorate in Medicine from Oxford University in 1993.  His current position is Professor and Graduate Coordinator in the Department of Nutritional Sciences, University of Toronto.  He has the following cross appointments: Professor, Department of Medicine, University of Toronto; Scientist, Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto; Member, Active Medical Staff, Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto; and Member, Consulting Medical Staff, Centre for Addiction and Mental Health, University of Toronto.  

Thomas Wolever’s research interests are the effects of dietary carbohydrates on human physiology and metabolism.  He is, perhaps, most well-known for work on the glycaemic index which was as first developed by Dr. David Jenkins and Dr. Wolever, along with other collaborators, while he was a medical student.  He has written or co-authored over 300 papers in peer-reviewed scientific journals, and also authored a book entitled: The Glycaemic Index: A Physiological Classification of Dietary Carbohydrate published in 2006 by CABI (www.cabi.org).  In 1997 he founded GI Testing, Inc. to provide confidential GI testing services to industry.  To cope with the high demand for GI testing and to enable a wider range of clinical research services to be provided, Glycemic Index Laboratories, Inc. (www.gilabs.com) was formed in 2004, a corporation of which Dr. Wolever is President. 

More important than anything else, Dr. Wolever is married with 3 children aged 26, 24 and 17 years.  He enjoys orienteering, cycling and recorder playing.